Literature DB >> 3053427

Characterization of a 95,000 molecule on sheep leucocytes homologous to murine Pgp-1 and human CD44.

C R Mackay1, J F Maddox, G L Wijffels, I R Mackay, I D Walker.   

Abstract

The phagocyte glycoprotein-1 (Pgp-1) antigen of mice is a 94,000 MW molecule with a wide tissue distribution, but no attributed function. We produced a monoclonal antibody (mAb) termed 25-32 which recognizes the Pgp-1 molecule of numerous mammalian species, including humans and sheep. Preclearing experiments with I42/5, a rat anti-mouse Pgp-1 mAb that cross-reacts with human Pgp-1, established the specificity of 25-32 for human and sheep Pgp-1. Moreover, an antibody recognizing human CD44, termed F10-44-2, also reacted with the same molecule as that recognized by 25-32 and I42/5, so establishing the co-identity of CD44 and Pgp-1. Within the sheep thymus, Pgp-1 was expressed most strongly by medullary thymocytes and stromal cells, and by small numbers of cells at the subcapsular cortex. Pgp-1 was expressed early in thymic ontogeny; all 35-40-day gestation fetal sheep thymocytes were intensely Pgp-1+, but by 80 days the number of reactive thymocytes had decreased to adult levels. The expression of Pgp-1 on lymphocytes was markedly increased after stimulation with mitogens, or with phorbol esters and ionomycin. The highly conserved nature of Pgp-1 through evolution, its expression on virtually all cell types within the body, and its increased expression on rapidly dividing cells indicate that this molecule mediates an important function, possibly serving as a hormone or metabolite receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053427      PMCID: PMC1385025     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  The sheep analogue of leucocyte common antigen (LCA).

Authors:  J F Maddox; C R Mackay; M R Brandon
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

4.  Evidence that the Pgp-1 glycoprotein is expressed on thymus-homing progenitor cells of the thymus.

Authors:  J Lesley; R Hyman; R Schulte
Journal:  Cell Immunol       Date:  1985-04-01       Impact factor: 4.868

5.  Biochemical characterisation and localization in brain of a human brain-leucocyte membrane glycoprotein recognised by a monoclonal antibody.

Authors:  J L McKenzie; R Dalchau; J W Fabre
Journal:  J Neurochem       Date:  1982-11       Impact factor: 5.372

6.  Monoclonal antibody to a human brain-granulocyte-T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat.

Authors:  R Dalchau; J Kirkley; J W Fabre
Journal:  Eur J Immunol       Date:  1980-10       Impact factor: 5.532

7.  Structural studies of murine lymphocyte surface IgD.

Authors:  J W Goding
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

8.  Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues.

Authors:  I S Trowbridge; J Lesley; R Schulte; R Hyman; J Trotter
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

9.  Genetic characterization of a polymorphic murine cell-surface glycoprotein.

Authors:  J Lesley; I S Trowbridge
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

10.  Identification and unusual tissue distribution of the canine and human homologues of Thy-1 (theta).

Authors:  R Dalchau; J W Fabre
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

View more
  9 in total

1.  A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin.

Authors:  L Y Bourguignon; V B Lokeshwar; J He; X Chen; G J Bourguignon
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  Selection of BoCD25 monoclonal antibodies by screening mouse L cells transfected with the bovine p55-interleukin-2 (IL-2) receptor gene.

Authors:  J Naessens; M Sileghem; N MacHugh; Y H Park; W C Davis; P Toye
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

3.  The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1.

Authors:  L Brooks; G Niedobitek; A Agathanggelou; P J Farrell
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

4.  CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues.

Authors:  H J Terpe; H Stark; P Prehm; U Günthert
Journal:  Histochemistry       Date:  1994-02

5.  The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins.

Authors:  M Culty; K Miyake; P W Kincade; E Sikorski; E C Butcher; C Underhill; E Silorski
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

6.  Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation.

Authors:  K J Hodivala; F M Watt
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

7.  Naive and memory T cells show distinct pathways of lymphocyte recirculation.

Authors:  C R Mackay; W L Marston; L Dudler
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

8.  Use of flow cytometry to develop and characterize a set of monoclonal antibodies specific for rabbit leukocyte differentiation molecules.

Authors:  William C Davis; Mary Jo Hamilton
Journal:  J Vet Sci       Date:  2008-03       Impact factor: 1.603

9.  Expression and modulation of CD44 variant isoforms in humans.

Authors:  C R Mackay; H J Terpe; R Stauder; W L Marston; H Stark; U Günthert
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.